Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   MIDDLE EAST JOURNAL OF DIGESTIVE DISEASES (MEJDD)   APRIL 2016 , Volume 8 , Number 2; Page(s) 116 To 121.
 
Paper: 

NONADHERENCE TO MEDICATION IN INFLAMMATORY BOWEL DISEASE: RATE AND REASONS

 
 
Author(s):  GHADIR MOHAMMAD REZA, BAGHERI MOHAMMAD, VAHEDI HOMAYOUN*, EBRAHIMI DARYANI NASSER, MALEKZADEH REZA, HORMATI AHMAD, KOLAHDOOZAN SHADI, CHAHARMAHALI MEGHEDI
 
* DIGESTIVE DISEASE RESEARCH CENTER, SHARIATI HOSPITAL, TEHRAN UNIVERSITY OF MEDICAL SCIENCES, TEHRAN, IRAN
 
Abstract: 

BACKGROUND: This study is the first study to evaluate the nonadherence rate and reasons of same patient with inflammatory bowel disease (IBD) in Iran.
METHODS During 9 months, 500 patients with IBD were enrolled in the study. Patients were interviewed about their nonadherence behaviors. Factor analysis was used to analyze the collected answers.
RESULTS: The overall rate of nonadherence was 33.3% (27.6% intentional nonadherence and 5.7% unintentional nonadherence).33.6% of the patients had at least one relapse after discontinuing treatment. The most frequent reason for intentional nonadherence was discontinuing the treatment after recovering from symptoms (42.7%). The most frequent reason for unintentional nonadherence was forgetfulness (5.2%).19.8% of the patients did not visit their gastroenterologist on time and they purchased drugs from the drugstore. These patients reported that their clinics were too far and difficult to access. There was no significant relationship between nonadherence and demographic variables.
CONCLUSION: Multiple reasons are suggested as factors of medication nonadherence and they seem to be different among different populations. Determining these possible reasons, could lead to finding suitable strategies to overcome or reduce them.

 
Keyword(s): ULCERATIVE COLITIS, CROHN’S DISEASE, NONADHERENCE, MEDICATION, TREATMENT
 
 
References: 
  • Not Registered.
  •  
  •  
 
Citations: 
  • Not Registered.
 
+ Click to Cite.
APA: Copy

GHADIR, M., & BAGHERI, M., & VAHEDI, H., & EBRAHIMI DARYANI, N., & MALEKZADEH, R., & HORMATI, A., & KOLAHDOOZAN, S., & CHAHARMAHALI, M. (2016). NONADHERENCE TO MEDICATION IN INFLAMMATORY BOWEL DISEASE: RATE AND REASONS. MIDDLE EAST JOURNAL OF DIGESTIVE DISEASES (MEJDD), 8(2), 116-121. https://www.sid.ir/en/journal/ViewPaper.aspx?id=511036



Vancouver: Copy

GHADIR MOHAMMAD REZA, BAGHERI MOHAMMAD, VAHEDI HOMAYOUN, EBRAHIMI DARYANI NASSER, MALEKZADEH REZA, HORMATI AHMAD, KOLAHDOOZAN SHADI, CHAHARMAHALI MEGHEDI. NONADHERENCE TO MEDICATION IN INFLAMMATORY BOWEL DISEASE: RATE AND REASONS. MIDDLE EAST JOURNAL OF DIGESTIVE DISEASES (MEJDD). 2016 [cited 2021July30];8(2):116-121. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=511036



IEEE: Copy

GHADIR, M., BAGHERI, M., VAHEDI, H., EBRAHIMI DARYANI, N., MALEKZADEH, R., HORMATI, A., KOLAHDOOZAN, S., CHAHARMAHALI, M., 2016. NONADHERENCE TO MEDICATION IN INFLAMMATORY BOWEL DISEASE: RATE AND REASONS. MIDDLE EAST JOURNAL OF DIGESTIVE DISEASES (MEJDD), [online] 8(2), pp.116-121. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=511036.



 
  pdf-File
Yearly Visit 57
 
 
Latest on Blog
Enter SID Blog